Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03549598 · ClinicalTrials.gov registry record · Phase 4
d68Ga-DOTATATE PET/CT Assessment of Cardiac Sarcoidosis
A Phase 4 study, sponsored by Mayo Clinic.
- Completed
- Registry status
- Phase 4
- Development phase
- 15
- Enrollment target
NCT03549598: Completed Phase 4 study, sponsored by Mayo Clinic.
NCT03549598 is a Phase 4 study that has completed, run by Mayo Clinic. The registered enrollment target is 15 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03549598, a Phase 4 study, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 15 participants
- Enrollment target
Study Summary
The Researchers are trying to determine if 68Ga-DOTATATE PET/CT imaging will have a similar accuracy as 18FDG PET/CT in diagnosing cardiac sarcoidosis and if it will be able to do so without the need for complex patient dietary preparation that is required with 18FDG PET/CT.
Primary Outcome
The number of subjects with areas of abnormal myocardial increased focal uptake
Interventions
- DRUG 68Ga-DOTATATE PET/CT
- DRUG 18FDG PET/CT scan
- DRUG 13NH3 PET/CT scan
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2018-07-20 |
| Est. Completion | 2019-10-02 |
| Phase | Phase 4 |
What the finished NCT03549598 record still lists
NCT03549598 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 15 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (97% lower).
The record links to 0 conditions, and to 3 interventions - of which 68Ga-DOTATATE PET/CT is the first listed.
NCT03549598 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03549598 about?
NCT03549598 is a clinical study titled "d68Ga-DOTATATE PET/CT Assessment of Cardiac Sarcoidosis". The Researchers are trying to determine if 68Ga-DOTATATE PET/CT imaging will have a similar accuracy as 18FDG PET/CT in diagnosing cardiac sarcoidosis and if it will be able to do so without the need for complex patient dietary preparation that is required with 18FDG PET/CT.
What is the current status of trial NCT03549598?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 15 participants. The study started on 2018-07-20. Estimated completion is 2019-10-02.
What interventions are being tested in trial NCT03549598?
The interventions under investigation include: 68Ga-DOTATATE PET/CT (DRUG), 18FDG PET/CT scan (DRUG), 13NH3 PET/CT scan (DRUG).
Who is sponsoring clinical trial NCT03549598?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03549598's enrollment target sits among peer trials
15 1880th of 2000 higher than 100 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01889381 · 15 participants · Phase 2
Human Craniomaxillofacial Allotransplantation
- NCT02530073 · 15 participants · NA
Trial of Fetoscopic Endoluminal Tracheal Occlusion (FETO) for CDH
- NCT02535936 · 15 participants · NA
Cortical Plasticity in Spastic Diplegia After Selective Dorsal Rhizotomy
- NCT02918474 · 15 participants · NA
Decision Making Tool in Supporting Decision Making in Contralateral Prophylactic Mastectomy in Patients With Newly Diagnosed Breast Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI